Page 2 - Charles Randquist News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Dec 10, 2020
SANTA BARBARA, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it recently received Institutional Review Board (IRB) approval to initiate a patient series in Costa Rica to study its Motiva Mia
® system for minimally invasive augmentation, which includes the Motiva Ergonomix2 Diamond
® breast implant, and has completed the procedure in the first 21 patients in the study.
“Motiva Mia is truly disruptive to traditional breast aesthetics,” said Dr. Charles Randquist, an internationally recognized plastic surgeon. “Minimally invasive breast enhancement should define a more balanced approach in aesthetics: an augmentation that is considerably more subtle in its sizing and approach and is performed without general anesthesia through a very small incision with ....

United States , Costa Rica , Davidk Erickson , Pablo Sol , Manuel Chac , Juan Jos , Alexandre Munhoz , Charles Randquist , Exchange Commission , Establishment Labs Holdings Inc , Securities Exchange , Establishment Lab , Paulo School Of Medicine , Labs Holdings , Institutional Review Board , Motiva Ergonomix , Paulo School , Motiva Mia , Motiva Implants , Establishment Labs , Motiva Implant , Simulation System , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Media Contact ,